(Q42068724)

16 October 2017

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). (English)

1 reference

16 October 2017

D W Cushman

1

1 reference

16 October 2017

F L Wang

2

1 reference

16 October 2017

W C Fung

3

1 reference

16 October 2017

G J Grover

4

1 reference

16 October 2017

C M Harvey

5

1 reference

16 October 2017

R J Scalese

6

1 reference

16 October 2017

S L Mitch

7

1 reference

16 October 2017

J M DeForrest

8

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

British Journal of Clinical Pharmacology

16 October 2017

1 reference

16 October 2017

28 Suppl 2

1 reference

16 October 2017

115S-130S; discussion 130S-131S

1 reference

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Angiotensin converting enzyme inhibitors. II. Clinical use.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Angiotensin converting enzyme inhibitors. I. Pharmacology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Converting-enzyme inhibitors in the treatment of hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Central and peripheral inhibition of angiotensin converting enzyme (ACE) in the SHR: correlation with the antihypertensive activity of ACE inhibitors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Heart and vascular wall as targets for tissue converting enzyme inhibition

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Pharmacology of converting enzyme inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Ramipril: review of pharmacology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Implications of local angiotensin production in cardiovascular physiology and pharmacology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Comparison of captopril and enalapril in patients with severe chronic heart failure

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Recent developments in the design of angiotensin-converting enzyme inhibitors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Disposition of fosinopril sodium in healthy subjects

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Evolution of angiotensin-converting enzyme inhibitors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Enalapril: a long-acting angiotensin-converting enzyme inhibitor

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Angiotensin-converting enzyme inhibitors. Emerging differences and new compounds

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

Influence of the Converting Enzyme Inhibitors Hoe 498, Enalapril and Captopril on Vascular Reactivity of Isolated Arterial Preparations

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379851

The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1989.TB03587.X

Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence

21 January 2018

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421

1 reference

12 December 2020

The Effects of Captopril on Rat Aortic Angiotensin-Converting Enzyme

1 reference

12 December 2020

Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498

1 reference

12 December 2020

Clinical pharmacology of ramipril

1 reference

12 December 2020

Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts

1 reference

12 December 2020

Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat

1 reference

12 December 2020

Possible role of vascular angiotensin converting enzyme in the genesis of hypertension

1 reference

12 December 2020

Studies on the angiotensin converting enzyme with different substrates

1 reference

12 December 2020

A solid silver clip for induction of predictable levels of renal hypertension in the rat

1 reference

12 December 2020

Effects of chronic administration of angiotensin converting enzyme (ACE) inhibitors on blood pressure and tissue ACE activity in the SHR

1 reference

12 December 2020

Tissue renin-angiotensin systems: focus on the heart

1 reference

12 December 2020

Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor binding

1 reference

12 December 2020

Local generation and release of angiotensin II in peripheral vascular tissue

1 reference

12 December 2020

Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril

1 reference

12 December 2020

Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme

1 reference

12 December 2020

Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement

1 reference

12 December 2020

Lisinopril: a new angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension

1 reference

12 December 2020

Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor

1 reference

12 December 2020

10.1111/J.1365-2125.1989.TB03587.X

Identifiers

DOI

1 reference

16 October 2017

1 reference

16 October 2017

1 reference